Haemophilia and thrombophilia
Escuriola, C.; Kurnik, K.; Schobess, R.; Horneff, S.; Kosch, A.; Kreuz, W.; Pollmann, H.; Nowak-Göttl, U. · Zeitschrift für Orthopädie und Unfallchirurgie · 2003 · Heft 01 · S. 36 bis 40
Bibliografische Angaben
Zusammenfassung
SummaryFor the study presented here 135 pediatric PUP patients with haemophilia consecutively admitted to German pediatric haemophilia treatment centers were investigated. In addition to factor VIII activity, the factor V (FV) G1691A mutation, the factor II (FII) G20210A variant, methylenetetrahydrofolate reductase (MTHFR) T677T genotype, elevated lipoprotein a (Lp a), antithrombin, protein C, and protein S were investigated. 103 out of 122 HA patients (FVIII activity